Bioelectronics & Precision Neuromodulation: The Next Therapeutic Frontier | Dr. Robert Spoelgen, Ph.D. - Vice President and Head of Bioelectronics, Merck KGaA Darmstadt Germany

Episode notes

Send us Fan Mail Imagine a device that can sense disease in real time… and treat it instantly. That’s the promise of Bioelectronics. Dr. Robert Spoelgen, Ph.D. is Vice President and Head of Bioelectronics at Merck KGaA Darmstadt Germany ( ), where he leads one of the company’s most forward-looking initiatives at the intersection of neuroscience, medical devices, and digital health. In this role, he founded and now drives Merck KGaA Darmstadt Germany’s bioelectronics strategy, focused on developing implantable neurostimulation technologies - particularly selective peripheral nerve stimulation platforms - to treat chronic diseases and enable real-time patient monitoring. Dr. Spoelgen’s work reflects a broader shift within pharma toward “beyond the pill” modalities, combining device-based therapies with data-driven insights. His team collaborates with medtech partners to develop precision neuromodulation approaches, including vagus nerve stimulation platforms aimed at conditions ranging from hypertension to inflammatory disease. Before launching bioelectronics at Merck KGaA Darmstadt Germany, Dr.

Related episodes across the Index

Other episodes covering the same guests and topics, from across The B2B Podcast Index.

• How Consumers Are Defining Healthcare's Future w/ Dr. Daniel Kraft, Founder, NextMed HealthCareTalk: Healthcare. Unfiltered. · on digital health81 / 100
• Disrupting Airlines, Streaming, and Healthcare for GoodThe Shift Code · on digital health79 / 100
• Neuroscience Tools For Leadership and Change with Dr. Lisa RiegelThe Talent Forge · on Vagus nerve79 / 100
• Niterra VenturesImpacTV · on digital health74 / 100
• Derek Baird from Switchboard HealthProduct in Healthtech · on digital health68 / 100
• Building Resilience In a Tough Sales World | Mark Divine - 2014The Sales Evangelist · on Vagus nerve64 / 100

• Building the Internet of Medicine: How AI Could Transform Children's Healthcare | Dr. Timothy Chou - Founder, Pediatric Moonshot92 / 100
• Inside the Global Biotech Ecosystem - Where Innovation Goes Next | Sara Jane Demy - Founder and CEO, Demy-Colton
• Reversing Cellular Age: The Scientist Who Helped Create iPS Cells Reveals What’s Next - Dr. Koji Tanabe, Ph.D. - Founder and CEO, I Peace Inc.
• The End of High Cholesterol? The First Oral PCSK9 Drug Could Change Heart Medicine Forever - Dr. Norman Lepor, MD - Founder and Director, National Heart Institute
• The Hidden Heart Risk: Amgen’s Dr. Paul Burton on the Future of Preventing Heart Attacks - Dr. Paul Burton, M.D., Ph.D., F.A.C.C., M.R.C.S., F.R.C.P. - Senior Vice President and Chief Medical Officer - Amgen